register

News - Pharmaceuticals

‘We must transcend silos in service of patients,’ says AbbVie VP & GM

Health Industry Hub | August 6, 2026 |

Healthcare leadership is being tested in ways that extends well beyond science, policy or commercial performance. In this Health Industry Hub senior leadership podcast, Nathalie McNeil, Vice President and General Manager of AbbVie ANZ, reflects on what it means to lead through complexity at a time when old assumptions are being challenged and the forces shaping decisions continue to evolve.

Drawing on three decades in healthcare and her experience leading AbbVie ANZ, McNeil explores the realities of navigating what leadership experts describe as a ‘decade of disorientation’, a period where complexity, ambiguity and shifting expectations are redefining how organisations operate and how leaders respond.

The discussion also turns to one of the defining issues facing organisations today: trust. As confidence in institutions and leadership continues to be tested, McNeil considers what this means for the healthcare sector and why rebuilding trust demands more than communication alone.

Another thread running through the episode is the emergence of the ‘Grounded Leader’, a leadership archetype increasingly associated with navigating today’s ambient uncertainty. What sets this approach apart, and why it is resonating in a rapidly changing world?

The episode also explores a tension familiar to many senior executives: balancing global priorities with local realities, organisational messaging with an authentic personal voice, and consistency with adaptability. It is a conversation about leadership that is both strategic and deeply human.

As organisations prepare for an increasingly unpredictable future, McNeil shares her perspective with the next generation of senior leaders on the mindset required to navigate complexity, embrace change and lead with purpose.

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News - Pharmaceuticals

Inside the tensions shaping PBAC decision

Inside the tensions shaping PBAC decision

Health Industry Hub | September 17, 2026 |

The evolving relationship between sponsors, the Pharmaceutical Benefits Advisory Committee (PBAC) and the health technology assessment (HTA) system came under […]

More


News - MedTech & Diagnostics

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

GenesisCare and Omico join forces in precision oncology as Australia sets national genomics agenda

Health Industry Hub | September 17, 2026 |

GenesisCare and Omico are teaming up to bring precision oncology to more patients facing incurable, advanced or poor prognosis cancers. […]

More


News - MedTech & Diagnostics

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

MTAA Board election kicks off, setting stage for the next chapter in policy and advocacy

Health Industry Hub | September 17, 2026 |

The race for six seats on the Medical Technology Association of Australia (MTAA) Board is underway, with 10 candidates nominated […]

More


News - Pharmaceuticals

New breast cancer drug fills gap left by Zoladex market withdrawal

New breast cancer drug fills gap left by Zoladex market withdrawal

Health Industry Hub | September 17, 2026 |

From 1 October 2026, Diphereline (triptorelin 3.75mg) will become available on the Pharmaceutical Benefits Scheme (PBS) for the treatment of […]

More


This content is copyright protected. Please subscribe to gain access.